ClinicalTrials.gov record
Not listed Phase 3 Interventional Accepts healthy volunteers

Interventions for Convergence Insufficiency in Concussed Children

ClinicalTrials.gov ID: NCT03908112

Public ClinicalTrials.gov record NCT03908112. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 8:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Interventions for Convergence Insufficiency in Concussed Children (ICONICC)

Study identification

NCT ID
NCT03908112
Recruitment status
Not listed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Mitchell Scheiman
Other
Enrollment
264 participants

Conditions and interventions

Interventions

  • SC plus Office-based Vergence/Accommodative Therapy (SC+OBVAT) Behavioral
  • SC plus Simple Convergence Exercises (SC+) Behavioral
  • Standard Community Concussion Care (SC) Behavioral

Behavioral

Eligibility (public fields only)

Age range
11 Years to 17 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2021
Primary completion
Mar 30, 2025
Completion
Mar 30, 2025
Last update posted
Oct 22, 2020

2021 – 2025

United States locations

U.S. sites
8
U.S. states
6
U.S. cities
8
Facility City State ZIP Site status
University of Alabama Birmingham Birmingham Alabama 35233
Marshall B. Ketchum University, Southern CA College of Optomwtry Fullerton California 92831
Stanford University Medical Center Palo Alto California 94304
Boston's Children's Hospital Boston Massachusetts 02453
New Jersey Institute of Technology Newark New Jersey 07102
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229
The Ohio State University College of Optometry Columbus Ohio 43210
Salus University/Children's Hospital of Philadelphia Philadelphia Pennsylvania 19141

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03908112, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 22, 2020 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03908112 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →